A major step forward, with important implications for understanding how to reduce the severity of
multiple sclerosis, has been made by scientists at the
University of Bristol. The results are published online today in PNAS.
The team found that mice designed to express a large amount of the neuropeptide ‘galanin’ were completely resistant to the MS-like disease, experimental autoimmune encephalomyelitis (EAE).